Serum prolidase activity in idiopathic and ischemic cardiomyopathy patients

Area of Science:

• Cardiology and Biochemistry
• Focuses on enzyme activity in cardiovascular disease

Background:

• Idiopathic and ischemic dilated cardiomyopathies (DCM) are leading causes of heart failure, characterized by cardiac fibrosis.
• Prolidase, an enzyme crucial for collagen turnover, has shown controversial associations with fibrotic conditions.
• Previous research suggests a link between fibrosis and prolidase activity, but direct measurement in DCM patients is lacking.

Purpose of the Study:

• To investigate and compare serum prolidase enzyme activity in patients diagnosed with idiopathic DCM and ischemic DCM.
• To establish baseline prolidase activity levels in these patient groups relative to healthy controls.
• To explore potential correlations between prolidase activity and the pathophysiology of dilated cardiomyopathies.

Main Methods:

• Serum samples were collected from patients with idiopathic DCM, ischemic DCM, and age-matched healthy volunteers.
• Prolidase enzyme activity was quantified using established biochemical assays.
• Statistical analyses were performed to compare enzyme activity across the three groups.

Main Results:

• Serum prolidase activity was significantly lower in both idiopathic and ischemic DCM patient groups compared to healthy controls.
• Patients with ischemic DCM exhibited lower serum prolidase activity than those with idiopathic DCM.
• These findings represent the first direct measurement of serum prolidase activity in DCM patients.

Conclusions:

• Reduced serum prolidase activity is observed in both idiopathic and ischemic dilated cardiomyopathies.
• The lower activity may reflect altered collagen turnover or reduced physical activity in DCM patients.
• Further research is necessary to elucidate the precise role of prolidase in DCM pathogenesis and its clinical implications.